Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 29:478-479, 2006
DOI: 10.2337/diacare.29.02.06.dc05-1770
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fadini, G. P.
Right arrow Articles by Avogaro, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fadini, G. P.
Right arrow Articles by Avogaro, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 29:478-479, 2006
© 2006 by the American Diabetes Association, Inc.


Letters: Comments and Responses
Letters: Comments and Responses

Autologous Transplantation of Granulocyte Colony–Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes

Response to Huang et al.

Gian Paolo Fadini, MD and Angelo Avogaro, MD, PHD

Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova Medical School, Padova, Italy

Address correspondence to Gian Paolo Fadini, MD, Dipartimento di Medicina Clinica e Sperimentale, Divisione di Malattie del Metabolismo, Policlinico Universitario, Via Giustiniani, 2, 35100 Padova, Italy. E-mail: gianpaolofadini@hotmail.com

The first 20% of the full text of this article appears below.

Huang et al. (1), in their small seminal clinical trial of cellular therapy for critical limb ischemia in diabetic patients, did not include presence of diabetic retinopathy among their exclusion criteria. It is known that individuals with diabetes are subjected to poor blood vessel growth in ischemic hearts and limbs and increased angiogenesis in retinal complications. This so-called "diabetic paradox" has been attributed . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
G. P. Fadini, S. Sartore, I. Baesso, M. Lenzi, C. Agostini, A. Tiengo, and A. Avogaro
Endothelial progenitor cells and the diabetic paradox.
Diabetes Care, March 1, 2006; 29(3): 714 - 716.
[Full Text] [PDF]


Home page
Diabetes CareHome page
B. Zhou, P. Huang, and Z. C. Han
Autologous Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes: Response to Fadini and Avogaro
Diabetes Care, February 1, 2006; 29(2): 479 - 480.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.